Dr. Karen Sims
Chief Medical Officer
Replay available
Arbutus Biopharma Corporation (ABUS) Q1 2024 Earnings Call
Arbutus Biopharma Corporation (NASDAQ: ABUS) Q1 2024 earnings conference call, held 2024-05-02. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Mike Sophia
Chief Scientific Officer
Dennis Ding
Analyst, Jefferies LLC
Mike McElhall
Interim President and Chief Executive Officer
Roy Buchanan
Analyst, Citizens JMP
David Hastings
Chief Financial Officer
Kia Nikkei
Analyst, Chardon Partners
Lisa Capparelli
Vice President, Investor Relations
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Arbutus Biopharma Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.758 Good day and thank you for standing by. Welcome to the Arbutus Biopharma 2024 First Quarter 00:00:04.758 -- 00:00:07.783 Financial Results and Corporate Update Conference Call. 00:00:07.783 -- 00:00:10.747 At this time, all participants are in a listen-only mode. 00:00:10.747 -- 00:00:14.413 After the speaker's presentation, there will be a question and answer session. 00:00:14.413 -- 00:00:18.579 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:18.579 -- 00:00:21.864 You will then hear an automated message advising your hand is raised. 00:00:21.864 -- 00:00:25.149 To withdraw your question, please press star 1-1 again. 00:00:25.149 -- 00:00:27.875 Please be advised that today's conference is being recorded. 00:00:27.875 -- 00:00:31.639 I would now like to hand the conference over to your first speaker today, Lisa Capparelli, 00:00:31.639 -- 00:00:35.682 Vice President of Investor Relations. Please go ahead. 00:00:35.682 -- 00:00:36.903 Thank you, Andrea. 00:00:36.903 -- 00:00:42.228 Good morning, everyone, and thank you for joining Arbutus' first quarter 2024 financial 00:00:42.228 -- 00:00:47.413 results and corporate update call. Joining me today from the Arbutus executive team 00:00:47.413 -- 00:00:52.338 are Mike McElhall, Interim President and Chief Executive Officer, Dr. 00:00:52.338 -- 00:00:58.013 Karen Sims, Chief Medical Officer, David Hastings, Chief Financial Officer, 00:00:58.013 -- 00:01:00.735 and Dr. Mike Sophia, Chief Scientific Officer. 00:01:00.735 -- 00:01:05.760 Mike McElhall will begin with a corporate update, followed by Karen, who 00:01:05.760 -- 00:01:08.923 will review our ongoing clinical programs. 00:01:08.923 -- 00:01:14.568 Dave will then provide a review ...